HOME >> BIOLOGY >> NEWS
Hopkins researcher finds bone disease and growth defect may have common genetic basis

An examination of two rare, very different and hereditary bone disorders has revealed clues about the common genetic switches controlling normal bone development, according to new research guided by Johns Hopkins Children's Center endocrinologist Michael Levine, M.D.

In the November issue of the Journal of Bone and Mineral Research, Levine's group describes two girls diagnosed with both Albright's hereditary osteodystrophy (AHO) and progressive osseous heteroplasia (POH). They found that abnormal bone formation was more severe in the two girls than in patients with AHO alone and that the girls' symptoms were more typical of POH, implying that the developmental and biochemical pathways leading to each condition intersect at some point along the way.

Both girls had severely depressed levels of an important protein called Gs-alpha that helps cells adjust their internal energy use in accordance with the body's needs, suggesting that metabolic pathways using Gs-alpha are the collective culprit behind AHO and POH. How mutant changes in these pathways lead to the development of bone in soft tissues remains unknown, Levine says, but researchers now know where to look.

Levine's group studied red blood cells from two girls, ages 7 and 10, and analyzed the many proteins that swim inside or on the surface of cell membranes. Using antibodies to selectively hunt down Gs-alpha and bind to it, they compared the concentrations of Gs-alpha in the red blood cells with that of normal red blood cells. In both girls, red blood cells contained about half as much Gs-alpha as normal red blood cells.

A gene, GNAS1, provides the DNA blueprint for Gs-alpha, a protein that plays a critical role in making sure a cell can respond to its external environment. Part of an elegantly complex metabolic system called a signal transduction pathway, normal levels of Gs-alpha make sure that cells can respond to hormones by changing which genes are turned on and off, a
'"/>

Contact: David Bricker
dbricker@jhmi.edu
410-223-1728
Johns Hopkins Medical Institutions
9-Nov-2000


Page: 1 2

Related biology news :

1. Hopkins scientists use blood proteins to detect ovarian cancer
2. Hopkins to found first center for comprehensive study of epigenetics
3. Hopkins scientists overcome main obstacle to making tons of short, drug-like proteins
4. Hopkins Marine Station honored by the American Society for Microbiology
5. Johns Hopkins gene hunters pinpoint new cancer gene target
6. Hopkins researchers identify transplantation antigens among Sioux Indians
7. Hopkins researchers discover how nitric oxide prevents blood vessel inflammation
8. Hopkins is first US institution to obtain powerful genotyping system
9. Dr. Robot tested at Hopkins
10. From Hopkins: Children may outgrow peanut allergies
11. OXiGENE announces launch of ophthalmic clinical trial at The Johns Hopkins School of Medicine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... , ... July 02, 2020 ... ... Systems, B.V. (MBS) has announced a publication detailing the use of its ... transcription polymerase chain reaction (RT-PCR) in 16 minutes. The article, titled "Ultra-fast ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... announced that it has entered into a multi-year contract with Merus N.V., ... their translational and clinical research strategy to discover and develop ground-breaking drugs. ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... and monoclonal antibody development services, today announced that the company has received ... to the pharmaceutical, diagnostics, and research industries. The decision to pursue ISO9001 ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... ... August 03, 2020 , ... Introducing Ardent Animal Health – MediVet Biologics rebrands ... , Known as MediVet Biologics since its formation in 2016, the company is ... Animal Health will build on its base of innovative therapies for osteoarthritis and cancer. ...
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... ... and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing ... announced that they have entered into a strategic partnership whereby Catalent will provide ...
(Date:7/18/2020)... ... 16, 2020 , ... After research model surgery and catheter implantation, the long ... only the beginning of a successful study, while protecting and accessing the catheter or ... Head of Surgery from Envigo in a live webinar on ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Technology (MIT) has expanded the company’s exclusive license to include clinical applications ... point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast ...
Breaking Biology Technology:
Cached News: